Dermatology
General Practice
Allergy
High Evidence
Peer reviewed

Topical Corticosteroids

Potency: Matching strength to the site and severity (e.g., Mild for face, Super-potent for palms).

Updated 5 Jan 2026
Reviewed 17 Jan 2026
9 min read
Reviewer
MedVellum Editorial Team
Affiliation
MedVellum Medical Education Platform

Clinical board

A visual summary of the highest-yield teaching signals on this page.

Urgent signals

Safety-critical features pulled from the topic metadata.

  • Skin atrophy/striae (STOP immediately)
  • Tachyphylaxis (Loss of efficacy)
  • Perioral dermatitis (Avoid facial fluorinated steroids)
  • Infected eczema (Use combination or treat infection first)

Linked comparisons

Differentials and adjacent topics worth opening next.

  • calcineurin-inhibitors
  • vitamin-d-analogues

Editorial and exam context

Reviewed by MedVellum Editorial Team · MedVellum Medical Education Platform

Credentials: MBBS, MRCP, Board Certified

Clinical reference article

Topical Corticosteroids (TCS)

1. Clinical Overview

Topical Corticosteroids (TCS) are the cornerstone of dermatologic therapy, used to treat a vast array of inflammatory conditions ranging from Atopic Dermatitis to Psoriasis and Lichen Planus. They function by binding to intracellular glucocorticoid receptors, suppressing the production of inflammatory cytokines (IL-1, IL-6, TNF-\alpha) and inducing vasoconstriction.

Success depends on the "The 4 Ps":

  1. Potency: Matching strength to the site and severity (e.g., Mild for face, Super-potent for palms).
  2. Preparation (Vehicle): Ointment for dry skin, Cream for weeping lesions, Lotion/Foam for hair.
  3. Pulse: Intermittent use to prevent side effects.
  4. Patient: Education on Fingertip Units (FTU) to avoid phobia or overuse.

Clinical Pearl:

The "Finger-Tip Unit" (FTU): One FTU is the amount of cream squeezed from the tube nozzle to the first crease of the adult index finger (~0.5g).

  • 1 FTU covers 2 Adult Hands (palm + fingers).
  • Face/Neck: 2.5 FTU.
  • One Arm: 3 FTU.
  • One Leg: 6 FTU.
  • Trunk (Front): 7 FTU.
  • Trunk (Back): 7 FTU.

2. Pharmacology & Classification

Mechanism of Action

  • Anti-inflammatory: Inhibits Phospholipase A2 $\rightarrow$ Reduces Arachidonic Acid $\rightarrow$ Reduces Prostaglandins/Leukotrienes.
  • Antimitotic: Inhibits DNA synthesis in epidermal cells (useful in psoriasis).
  • Vasoconstrictive: Reduces erythema (used as a surrogate marker for potency).

The Potency Ladder (Introduction)

Potency depends on the molecule and the vehicle. Betamethasone Valerate Ointment is stronger than Betamethasone Valerate Cream.

  • USA System (Class 1-7): Class 1 is Super Potent. Class 7 is Mild.
  • UK/WHO System (Class I-IV): Class I is Mild. Class IV is Very Potent. (We will reference the descriptive terms to avoid confusion).

The "Ladder" (Descriptive)

  1. Mild: Hydrocortisone 0.5-2.5%.
  2. Moderate: Clobetasone Butyrate (Eumovate).
  3. Potent: Betamethasone Valerate (Betnovate), Mometasone Furoate (Elocon).
  4. Super-Potent: Clobetasol Propionate (Dermovate), Betamethasone Dipropionate.

3. Vehicles: Choosing the Right Base

The effectiveness of a steroid is determined by its ability to penetrate the stratum corneum.

VehiclePropertiesBest ForWorst For
OintmentGrease-based (paraffin/oil). Occlusive. Hydrating. Highest Potency.Dry, lichenified, thick skin (Psoriasis, chronic Eczema).Weeping lesions (traps bacteria), Face (greasy), Hairy areas.
CreamWater-in-oil emulsion. Cosmestically elegant. Absorbs quickly. Contains preservatives.Acute, weeping eczema. Flexures. Face.Very dry skin (less moisturizing).
Lotion/SolnHigh water/alcohol content. Evaporates. Drying.Scalp (hair), Hairy chest. Exudative lesions.Dry skin (stings).
Foam/MoussePressurized gas. Spreads easily.Scalp, large body surface areas.Expensive.
TapeSteroid impregnated tape (Cordran). Highly occlusive.Stubborn isolated plaques (Lichen Simplex).Widespread disease.

4. Indications & Contraindications

Primary Indications (Responsive)

  • Atopic Dermatitis (Eczema): The gold standard.
  • Psoriasis: Especially flexural or localized plaques.
  • Lichen Planus: Potent steroids required.
  • Discoid Lupus Erythematosus: Requires potent/super-potent.
  • Allergic Contact Dermatitis: Poison Ivy, Nickel allergy.
  • Seborrheic Dermatitis: Use mild/moderate + antifungal.

Relative Contraindications (Use with Caution)

  • Perioral Dermatitis / Rosacea: NEVER use potent steroids on the face. It exacerbates the condition ("Steroid Rosacea").
  • Active Infection:
    • Fungal (Tinea): Causes "Tinea Incognito" (altered appearance, spread).
    • Viral (Herpes/Shingles): Can worsen viral replication.
    • Bacterial (Impetigo): Treat infection first.
  • Ulcerated Skin: Impairs wound healing.

5. Dosage & Application (The Protocol)

"Finger-Tip Unit" (FTU) Dosage Table

Body PartAdult FTUs (approx)Grams per Application
Face & Neck2.51.25g
Trunk (Front & Back)14 (7+7)7g
One Arm31.5g
One Hand10.5g
One Leg63g
One Foot21g

Frequency

  • Once Daily (OD): Newer steroids (Mometasone, Fluticasone) deposit in the stratum corneum and release slowly. OD is often sufficient and improves adherence.
  • Twice Daily (BD): Older steroids (Hydrocortisone, Betamethasone).
  • More than BD: NO benefit. Increases side effects and tachyphylaxis.

Duration

  • Face/Genitals: Max 1-2 weeks of Mild/Moderate.
  • Body: Can use Potent for 2-4 weeks, then taper.
  • Maintenance: "Weekend Therapy" (Sat/Sun application) reduces flare frequency in chronic eczema.

6. Adverse Effects (local & Systemic)

Local (Common)

  1. Atrophy (Thinning): Decreased collagen. Skin looks transparent, wrinkled. Senile purpura look-alike.
  2. Striae (Stretch Marks): Irreversible rupture of dermal collagen. Crucial to avoid in puberty/pregnancy.
  3. Telangiectasia: Permanent dilation of capillaries.
  4. Tachyphylaxis: Tolerance. The drug stops working after prolonged use. Requires a "drug holiday."
  5. Perioral Dermatitis: Pustular eruption around mouth/nose from facial steroid abuse.
  6. Glaucoma/Cataracts: From application near the eyes (eyelids transport drug to anterior chamber).

Systemic (Rare, but possible with Super-Potent > 50g/week)

  1. Suppression of HPA Axis: adrenal insufficiency upon withdrawal.
  2. Cushing's Syndrome: Moon face, buffalo hump (rare in adults, risk in infants).
  3. Growth Retardation: In children with widespread use.

7. Management Regimens by Site

SitePreferred PotencyPreferred VehicleDuration LimitClinical Pearl
FaceMild (Hydrocortisone 1%)Cream / Ointment5-7 daysEyelids are ultra-thin (0.5mm); highest absorption. Caution!
Axilla / GroinMild / Moderate (Eumovate)Cream7-14 daysOcclusive environment increases absorption 10-fold.
Trunk / LimbsPotent (Betnovate/Elocon)Ointment (Dry) / Cream (Wet)2-4 weeksThe "Workhorse" area. Can tolerate potent steroids well.
Palms / SolesSuper-Potent (Dermovate)Ointment2-4 weeksThickest skin (4mm). Needs strongest drug to penetrate. Use occlusion.
ScalpPotent / Super-PotentLotion / Foam / ShampooIndefinite (Pulse)Very resistant to atrophy. Can use strong steroids liberally.

8. Complications: TSW and Phobia

Topical Steroid Withdrawal (TSW) / "Red Skin Syndrome"

  • Concept: controversial entity. Rebound vasodilation and cytokine storm after stopping long-term potent steroids.
  • Signs: Bright red, burning skin (sleeves/red face), edema, "elephant skin" (wrinkling) sparing the palms/soles.
  • Prevention: Tapering doses. Don't stop abruptly. Use steroid-sparing agents (Tacrolimus).

Steroid Phobia

  • Prevalence: Up to 80% of parents/patients fear steroids.
  • Consequence: Under-treatment $\rightarrow$ Chronic inflammation $\rightarrow$ Lichenification $\rightarrow$ Need for stronger steroids later.
  • Counseling: "Used correctly (fingertip units, right duration), spread thin, they are safe. Uncontrolled eczema affects growth and sleep more than the cream will."

9. Integrated Care: "The Steroid Ladder"

Start with the lowest potency that controls disease ("Step-Up") OR Start high to gain control then taper ("Step-Down"

  • preferred for flares).

Step 1: Mild

  • Hydrocortisone 0.5%, 1%, 2.5%
  • Use: Face, Eyelids, Infants, Maintenance.

Step 2: Moderate

  • Clobetasone Butyrate 0.05% (Eumovate)
  • Triamcinolone Acetonide 0.025%
  • Use: Axilla, Groin, extensive childhood eczema.

Step 3: Potent

  • Betamethasone Valerate 0.1% (Betnovate)
  • Mometasone Furoate 0.1% (Elocon) - Once Daily
  • Fluocinolone Acetonide
  • Use: Body eczema, Psoriasis, Lichen Planus.

Step 4: Super-Potent

  • Clobetasol Propionate 0.05% (Dermovate)
  • Betamethasone Dipropionate (Diprosone)
  • Use: Psoriasis plaques, Palms/Soles, Discoid Lupus, Lichen Sclerosus. Max 50g/week.

10. Steroid-Sparing Alternatives

When steroids fail, cause side effects, or are needed long-term on sensitive sites.

  1. Calcineurin Inhibitors (TCIs):
    • Tacrolimus (Protopic), Pimecrolimus (Elidel).
    • Mechanism: Inhibit T-cell activation. Not a steroid. No atrophy.
    • Use: Face, Eyelids, Groin maintenance.
    • Side Effect: Burning sensation on application (improves after 3-4 days).
  2. Vitamin D Analogues:
    • Calcipotriol.
    • Use: Psoriasis (often combined with steroid: Dovobet).
  3. Phosphodiesterase-4 (PDE4) Inhibitors:
    • Crisaborole (Eucrisa).
    • Use: Mild-moderate Atopic Dermatitis.

11. Evidence & Guidelines

Efficacy Data

  • Cochrane Reviews: Potent steroids are superior to mild for induction of remission in moderate-severe eczema. Once daily potent (Mometasone) is as effective as twice daily.
  • Preventative Therapy: "Weekend Therapy" (application to previous flare sites 2 days/week) significantly delays relapse in AD (Reduce relapse by 50-70%).

Guidelines (AAD / BAD)

  • Atopic Dermatitis: Hydration (emollients) is baseline. Add steroids for flares.
  • Psoriasis: Potent steroid + Vit D analogue is Gold Standard topical.
  • Pregnancy: Mild/Moderate is safe. Potent should be used sparingly if benefits outweigh risks (small risk of low birth weight).

12. Future Horizons

  • JAK Inhibitors (Topical): Ruxolitinib cream. Highly effective for eczema/vitiligo. Non-steroidal.
  • Tapinarof: Aryl hydrocarbon receptor agonist. Steroid-free cream for psoriasis.
  • Soft Drugs: Steroids that are metabolically inactivated locally (Ante-drugs) to reduce systemic absorption (e.g., Methylprednisolone aceponate).

13. Special Populations

A. Infants & Children

  • High Body Surface Area to Weight ratio = High systemic absorption risk.
  • Use Mild/Moderate mostly. Potent only for short bursts (3-5 days) for severe flares.
  • Avoid potent on face/nappy area (occlusion by diaper increases absorption).

B. Pregnancy & Breastfeeding

  • Pregnancy: Generally safe. Avoid massive quantities. Mild/Moderate preferred.
  • Lactation: Safe. Apply after feeding or wash off nipple area before feeding.

C. The Elderly

  • Skin is naturally thinner (atrophic). More prone to tearing/bruising.
  • Use lower potency if possible. Monitor for "Senile Purpura."

14. Patient Education

The "Sandwich Technique"? (Myth Busting)

  • Old Advice: Wait 30 mins between moisturizer and steroid.
  • Current Advice: Doesn't matter which goes first, or if you wait. Just get them both on. Ideally, apply moisturizer liberally, wait a few minutes for absorption, then apply steroid to red/itchy areas.

"Steroids Thin the Skin"

  • The Nuance: "Yes, they can if used incorrectly. But scratching eczema destroys the skin barrier faster. Using the cream for 2 weeks to heal the skin actually restores the barrier."

15. Case Mastery: Clinical Scenarios

Case 1: The "Red Face" Rebound

Patient: 25yo female. Used "Betnovate" on face for 3 months for mild rash. Now has pustules and burning redness around mouth. Diagnosis: Perioral Dermatitis (Steroid Rosacea). Management: STOP STEROID. (Taper if possible, but tough). Start Oral Tetracycline (Lymecycline) + Topical Metronidazole / Protopic. Warn about "flare" upon stopping.

Case 2: The "Stubborn Patch"

Patient: 60yo male. Thick, itchy plaque on ankle for 5 years. Steroid creams "don't work." Diagnosis: Lichen Simplex Chronicus (Neurodermatitis). Thick skin (lichenification) prevents absorption. Management: Super-Potent (Dermovate) Ointment under Occlusion (wrap in cling film or zinc paste bandage) overnight. Breaking the itch-scratch cycle is key.

Case 3: The "Tinea Incognito"

Patient: Rash on groin treated with Hydrocortisone for weeks. Rash got bigger, ring-shaped, less scaly but more red. Diagnosis: Fungal infection modified by steroid. Management: Stop steroid. Oral Antifungal (Terbinafine).


16. Appendix: Additional Resources

Useful Abbreviations

AbbreviationMeaning
TCSTopical Corticosteroid
FTUFingertip Unit
TSWTopical Steroid Withdrawal
LSCLichen Simplex Chronicus
OD/BDOnce Daily / Twice Daily

Online Tools

Learning map

Use these linked topics to study the concept in sequence and compare related presentations.

Prerequisites

Start here if you need the foundation before this topic.

  • skin-anatomy
  • inflammation-pathways

Differentials

Competing diagnoses and look-alikes to compare.

  • calcineurin-inhibitors
  • vitamin-d-analogues
  • emollients

Consequences

Complications and downstream problems to keep in mind.

  • skin-atrophy
  • tachyphylaxis
  • topical-steroid-withdrawal